The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Modafinil, sold under the brand name Provigil among others, is a central nervous system (CNS) stimulant medication used to treat sleepiness due to narcolepsy, shift work sleep disorder, and obstructive sleep apnea
Global Modafinil market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Modafinil market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Modafinil market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Welman Pharma
Orion
Acino
Teva
Alembic Pharma
Apotex
Appco Pharma
Arrow Pharma
Ascent Innovative Medicines
Auro Laboratories
Aurobindo Pharma
Cadila Pharma
Sun Pharma
Cephalon
Chanelle Medical
Segment by Type
100Mg
200Mg
Segment by Application
Narcolepsy
Multiple Sclerosis (MS) Fatigue
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Modafinil report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Modafinil, sold under the brand name Provigil among others, is a central nervous system (CNS) stimulant medication used to treat sleepiness due to narcolepsy, shift work sleep disorder, and obstructive sleep apnea
Global Modafinil market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Modafinil market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Modafinil market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Welman Pharma
Orion
Acino
Teva
Alembic Pharma
Apotex
Appco Pharma
Arrow Pharma
Ascent Innovative Medicines
Auro Laboratories
Aurobindo Pharma
Cadila Pharma
Sun Pharma
Cephalon
Chanelle Medical
Segment by Type
100Mg
200Mg
Segment by Application
Narcolepsy
Multiple Sclerosis (MS) Fatigue
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Modafinil report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Modafinil Market Overview
1.1 Product Overview and Scope of Modafinil
1.2 Modafinil Segment by Type
1.2.1 Global Modafinil Market Value Comparison by Type (2023-2029)
1.2.2 100Mg
1.2.3 200Mg
1.3 Modafinil Segment by Application
1.3.1 Global Modafinil Market Value by Application: (2023-2029)
1.3.2 Narcolepsy
1.3.3 Multiple Sclerosis (MS) Fatigue
1.4 Global Modafinil Market Size Estimates and Forecasts
1.4.1 Global Modafinil Revenue 2018-2029
1.4.2 Global Modafinil Sales 2018-2029
1.4.3 Global Modafinil Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Modafinil Market Competition by Manufacturers
2.1 Global Modafinil Sales Market Share by Manufacturers (2018-2023)
2.2 Global Modafinil Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Modafinil Average Price by Manufacturers (2018-2023)
2.4 Global Modafinil Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Modafinil, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Modafinil, Product Type & Application
2.7 Modafinil Market Competitive Situation and Trends
2.7.1 Modafinil Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Modafinil Players Market Share by Revenue
2.7.3 Global Modafinil Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Modafinil Retrospective Market Scenario by Region
3.1 Global Modafinil Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Modafinil Global Modafinil Sales by Region: 2018-2029
3.2.1 Global Modafinil Sales by Region: 2018-2023
3.2.2 Global Modafinil Sales by Region: 2024-2029
3.3 Global Modafinil Global Modafinil Revenue by Region: 2018-2029
3.3.1 Global Modafinil Revenue by Region: 2018-2023
3.3.2 Global Modafinil Revenue by Region: 2024-2029
3.4 North America Modafinil Market Facts & Figures by Country
3.4.1 North America Modafinil Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Modafinil Sales by Country (2018-2029)
3.4.3 North America Modafinil Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Modafinil Market Facts & Figures by Country
3.5.1 Europe Modafinil Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Modafinil Sales by Country (2018-2029)
3.5.3 Europe Modafinil Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Modafinil Market Facts & Figures by Country
3.6.1 Asia Pacific Modafinil Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Modafinil Sales by Country (2018-2029)
3.6.3 Asia Pacific Modafinil Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Modafinil Market Facts & Figures by Country
3.7.1 Latin America Modafinil Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Modafinil Sales by Country (2018-2029)
3.7.3 Latin America Modafinil Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Modafinil Market Facts & Figures by Country
3.8.1 Middle East and Africa Modafinil Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Modafinil Sales by Country (2018-2029)
3.8.3 Middle East and Africa Modafinil Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Modafinil Sales by Type (2018-2029)
4.1.1 Global Modafinil Sales by Type (2018-2023)
4.1.2 Global Modafinil Sales by Type (2024-2029)
4.1.3 Global Modafinil Sales Market Share by Type (2018-2029)
4.2 Global Modafinil Revenue by Type (2018-2029)
4.2.1 Global Modafinil Revenue by Type (2018-2023)
4.2.2 Global Modafinil Revenue by Type (2024-2029)
4.2.3 Global Modafinil Revenue Market Share by Type (2018-2029)
4.3 Global Modafinil Price by Type (2018-2029)
5 Segment by Application
5.1 Global Modafinil Sales by Application (2018-2029)
5.1.1 Global Modafinil Sales by Application (2018-2023)
5.1.2 Global Modafinil Sales by Application (2024-2029)
5.1.3 Global Modafinil Sales Market Share by Application (2018-2029)
5.2 Global Modafinil Revenue by Application (2018-2029)
5.2.1 Global Modafinil Revenue by Application (2018-2023)
5.2.2 Global Modafinil Revenue by Application (2024-2029)
5.2.3 Global Modafinil Revenue Market Share by Application (2018-2029)
5.3 Global Modafinil Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Welman Pharma
6.1.1 Welman Pharma Corporation Information
6.1.2 Welman Pharma Description and Business Overview
6.1.3 Welman Pharma Modafinil Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Welman Pharma Modafinil Product Portfolio
6.1.5 Welman Pharma Recent Developments/Updates
6.2 Orion
6.2.1 Orion Corporation Information
6.2.2 Orion Description and Business Overview
6.2.3 Orion Modafinil Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Orion Modafinil Product Portfolio
6.2.5 Orion Recent Developments/Updates
6.3 Acino
6.3.1 Acino Corporation Information
6.3.2 Acino Description and Business Overview
6.3.3 Acino Modafinil Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Acino Modafinil Product Portfolio
6.3.5 Acino Recent Developments/Updates
6.4 Teva
6.4.1 Teva Corporation Information
6.4.2 Teva Description and Business Overview
6.4.3 Teva Modafinil Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Teva Modafinil Product Portfolio
6.4.5 Teva Recent Developments/Updates
6.5 Alembic Pharma
6.5.1 Alembic Pharma Corporation Information
6.5.2 Alembic Pharma Description and Business Overview
6.5.3 Alembic Pharma Modafinil Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Alembic Pharma Modafinil Product Portfolio
6.5.5 Alembic Pharma Recent Developments/Updates
6.6 Apotex
6.6.1 Apotex Corporation Information
6.6.2 Apotex Description and Business Overview
6.6.3 Apotex Modafinil Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Apotex Modafinil Product Portfolio
6.6.5 Apotex Recent Developments/Updates
6.7 Appco Pharma
6.6.1 Appco Pharma Corporation Information
6.6.2 Appco Pharma Description and Business Overview
6.6.3 Appco Pharma Modafinil Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Appco Pharma Modafinil Product Portfolio
6.7.5 Appco Pharma Recent Developments/Updates
6.8 Arrow Pharma
6.8.1 Arrow Pharma Corporation Information
6.8.2 Arrow Pharma Description and Business Overview
6.8.3 Arrow Pharma Modafinil Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Arrow Pharma Modafinil Product Portfolio
6.8.5 Arrow Pharma Recent Developments/Updates
6.9 Ascent Innovative Medicines
6.9.1 Ascent Innovative Medicines Corporation Information
6.9.2 Ascent Innovative Medicines Description and Business Overview
6.9.3 Ascent Innovative Medicines Modafinil Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Ascent Innovative Medicines Modafinil Product Portfolio
6.9.5 Ascent Innovative Medicines Recent Developments/Updates
6.10 Auro Laboratories
6.10.1 Auro Laboratories Corporation Information
6.10.2 Auro Laboratories Description and Business Overview
6.10.3 Auro Laboratories Modafinil Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Auro Laboratories Modafinil Product Portfolio
6.10.5 Auro Laboratories Recent Developments/Updates
6.11 Aurobindo Pharma
6.11.1 Aurobindo Pharma Corporation Information
6.11.2 Aurobindo Pharma Modafinil Description and Business Overview
6.11.3 Aurobindo Pharma Modafinil Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Aurobindo Pharma Modafinil Product Portfolio
6.11.5 Aurobindo Pharma Recent Developments/Updates
6.12 Cadila Pharma
6.12.1 Cadila Pharma Corporation Information
6.12.2 Cadila Pharma Modafinil Description and Business Overview
6.12.3 Cadila Pharma Modafinil Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Cadila Pharma Modafinil Product Portfolio
6.12.5 Cadila Pharma Recent Developments/Updates
6.13 Sun Pharma
6.13.1 Sun Pharma Corporation Information
6.13.2 Sun Pharma Modafinil Description and Business Overview
6.13.3 Sun Pharma Modafinil Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Sun Pharma Modafinil Product Portfolio
6.13.5 Sun Pharma Recent Developments/Updates
6.14 Cephalon
6.14.1 Cephalon Corporation Information
6.14.2 Cephalon Modafinil Description and Business Overview
6.14.3 Cephalon Modafinil Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Cephalon Modafinil Product Portfolio
6.14.5 Cephalon Recent Developments/Updates
6.15 Chanelle Medical
6.15.1 Chanelle Medical Corporation Information
6.15.2 Chanelle Medical Modafinil Description and Business Overview
6.15.3 Chanelle Medical Modafinil Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Chanelle Medical Modafinil Product Portfolio
6.15.5 Chanelle Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Modafinil Industry Chain Analysis
7.2 Modafinil Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Modafinil Production Mode & Process
7.4 Modafinil Sales and Marketing
7.4.1 Modafinil Sales Channels
7.4.2 Modafinil Distributors
7.5 Modafinil Customers
8 Modafinil Market Dynamics
8.1 Modafinil Industry Trends
8.2 Modafinil Market Drivers
8.3 Modafinil Market Challenges
8.4 Modafinil Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
